Loading...
Loading...
Median short interest for listed and OTC Life Science Research Supply stocks fell 7% in the first half of October, while aggregate short interest for the group slid 4% to the lowest levels since May 2006 (vs. declines of 2% and 5% for the NYSE and Nasdaq, respectively), Jefferies & Company reports.
“Short interest levels decreased for 17 of the 21 constituents in our life science research supplies index,” Jefferies & Company writes.
Becton, Dickinson and Company
BDX experienced the most dramatic decline at -20%.
Becton, Dickinson and Company currently trades at $76.73.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in